Document:

Exhibit
4.3

WARRANT AGENT AGREEMENT

THIS
WARRANT AGENT AGREEMENT (this “Warrant Agent Agreement”) dated as of April __, 2020 (the “Issuance
Date”), by and between Modular Medical, Inc., a company incorporated under the laws of the State of Nevada (the “Company”),
and ________ (the “Warrant Agent”). All capitalized terms used herein and not otherwise defined shall have
the meanings ascribed to them in the Warrants (as defined below).

WHEREAS,
the Company is engaged in a best efforts public offering (the “Offering”) of up to 2,000,000 units (the “Units”)
consisting of an aggregate of (i) 2,000,000 shares (the “Shares”) of Series A 13% Cumulative Redeemable Perpetual
Preferred Stock (the “Series A Preferred Stock”), and (ii) 6,000,000 warrants (the “Warrants”)
to purchase shares (the “Warrant Shares”) of common stock, par value $0.001 per share (the “Common
Stock”).

WHEREAS,
the Company has filed with the Securities and Exchange Commission (the “Commission”) a Registration Statement
on Form S-1 (File No. 333-____) (as the same may be amended from time to time, the “Registration Statement”),
for the registration under the Securities Act of 1933, as amended (the “Securities Act”), of the Units, the
Shares, the Warrants, and the Warrant Shares, and such Registration Statement was declared effective by the Commission on ____
__, 2020.

WHEREAS,
the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing so to act, in accordance
with the terms set forth in this Warrant Agent Agreement in connection with the issuance, registration, transfer, exchange, and
exercise of the Warrants.

WHEREAS,
the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised,
and the respective rights, limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of the Warrants.

WHEREAS,
all acts and things have been done and performed that are necessary to make the Warrants the valid, binding, and legal obligations
of the Company, and to authorize the execution and delivery of this Warrant Agent Agreement.

NOW,
THEREFORE, in consideration of the mutual agreements herein contained, and for other good and valuable consideration, the
adequacy, sufficiency, and receipt of which are hereby acknowledged, the parties hereto agree as follows: 

1.            Appointment of the Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company with respect
to the Warrants, and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the express
terms and conditions set forth in this Warrant Agent Agreement (and no implied terms or conditions).

    	 

    	 

    

2.            Warrants.

		2.1.	Form
                                         of Warrants. Each Warrant shall be (a) issued in book-entry form or (b) in substantially
                                         in the form of Exhibit A attached hereto, the provisions of which are
                                         incorporated herein, and signed by, or bear the .pdf signature of, the Chief Executive
                                         Officer or Chief Financial Officer, or such other officer of the Company as the Company
                                         may designate with written notice to the Warrant Agent (each, an “Authorized
                                         Signatory”; and, collectively, the “Authorized Signatories”).
                                         In the event the person whose .pdf signature has been placed upon any Warrant shall have
                                         ceased to serve in the capacity in which such person signed the Warrant before such warrant
                                         is issued, it may be issued with the same effect as if he or she had not ceased to be
                                         such at the date of issuance. All of the Warrants shall initially be represented by one
                                         or more book-entry positions (each, a “Book-Entry Warrant”).

		2.2.	Issuance
                                         and Registration of Warrants.

		2.2.1.	Warrant
                                         Register. The Warrant Agent shall maintain books (the “Warrant Register”)
                                         for the registration of the original issuance and the registration of all transfers of
                                         the Warrants.

		2.2.2.	Issuance
                                         of Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue
                                         and register the Warrants in the names of the respective holders thereof in such denominations
                                         and otherwise in accordance with the instructions delivered to the Warrant Agent by the
                                         Company. To the extent the Warrants are Depository Trust Company (“DTC”)
                                         eligible as of the Issuance Date, all of the Warrants shall be represented by one or
                                         more Book-Entry Warrants deposited with DTC and registered in the name of Cede &
                                         Co., a nominee of DTC. Ownership of beneficial interests in the Book-Entry Warrants shall
                                         be shown on, and the transfer of such ownership shall be effected through, records maintained
                                         (i) by DTC or its nominee for each Book-Entry Warrant; (ii) by institutions that have
                                         accounts with DTC (such institution, with respect to a Warrant in its account, a “Participant”);
                                         or (iii) directly on the book-entry records of the Warrant Agent with respect only to
                                         owners of beneficial interests that represent such direct registration. If the Warrants
                                         are not DTC Eligible as of the Issuance Date or DTC subsequently ceases to make its book-entry
                                         settlement system available for the Warrants, the Company may instruct the Warrant Agent
                                         in writing regarding making other arrangements for book-entry settlement within ten (10)
                                         days after DTC ceases to make its book-entry settlement available. In the event that
                                         the Company does not make alternative arrangements for book-entry settlement within ten
                                         (10) days of when the Warrants are not eligible for, or it is no longer necessary to
                                         have the Warrants available in, book-entry form, the Warrant Agent shall provide written
                                         instructions to DTC to deliver to the Warrant Agent for cancellation of each Book-Entry
                                         Warrant, and the Company shall instruct the Warrant Agent to deliver to DTC definitive
                                         certificates in physical form evidencing such Warrants in substantially the form annexed
                                         hereto as Exhibit A.

		2.2.3.	Beneficial
                                         Owner; Registered Holder. Prior to due presentment for registration of transfer of
                                         any Warrant, the Company and the Warrant Agent may deem and treat the person in whose
                                         name that Warrant shall be registered on the Warrant Register (the “Registered
                                         Holder”) as the absolute owner of such Warrant for purposes of any exercise
                                         thereof, and for all other purposes, and neither the Company nor the Warrant Agent shall
                                         be affected by any notice to the contrary. Any person in whose name ownership of a beneficial
                                         interest in the Warrants evidenced by a Book-Entry Warrant is recorded in the records
                                         maintained by DTC or its nominee shall be deemed the “beneficial owner” thereof.

    	2

    	 

    
		2.2.4.	Physical
                                         Certificate .
                                         Notwithstanding anything contained herein, a Registered Holder or if the Book-Entry Warrants
                                         are deposited with DTC, the beneficial owner, has the right, upon written notice to the
                                         Warrant Agent (in form and substance reasonably acceptable to the Warrant Agent), to
                                         request a physical warrant certificate in substantially the form of Exhibit A,
                                         attached hereto, as applicable, for up to the same number of Warrants as are registered
                                         in the name of such Registered Holder or beneficial owner, as applicable, in the records
                                         maintained by the Warrant Agent (a “Warrant Certificate”). Such Warrant
                                         Certificate shall be dated as of the original Issuance Date and shall be executed by
                                         an Authorized Signatory. The Warrant Agent shall deliver the Warrant Certificate to the
                                         Registered Holder as promptly as practicable.

3.            Exercise of Warrants. Subject to the provisions of the Warrants and this Warrant Agent Agreement, a Warrant may be exercised
by the Registered Holder thereof by delivering to the Warrant Agent and to the Company, the notice of exercise, as set forth in
the Warrant, duly executed and properly completed, and by paying in full, in lawful money of the United States by wire transfer
to the Company (or, if available, pursuant to the cashless exercise feature as set forth in such Warrant, all cashless exercises
should be directed to the Company for calculation of the applicable number of Warrant Shares issuable upon such cashless exercise
and upon completion of such calculation by the Company, the Company shall provide the Warrant Agent with issuance instructions),
the Exercise Price for each full Warrant Share as to which the Warrant is exercised and the issuance of the Warrant Shares by
the Warrant Agent as set forth in the applicable Warrant. No ink-original Notice of Exercise is required to be delivered, nor
shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.

4.            Concerning the Warrant Agent and Other Matters.

		4.1.	Payment
                                         of Taxes. The Company will, from time to time, promptly pay all taxes and charges
                                         that may be imposed upon the Company or the Warrant Agent in respect of the issuance
                                         or delivery of Warrant Shares upon the exercise of Warrants, but the Company shall not
                                         be required to pay any transfer taxes in respect of the Warrants or such Warrant Shares.
                                         The Warrant Agent may refrain from registering any transfer of Warrants or any delivery
                                         of any Warrant Shares unless or until the persons requesting the registration or issuance
                                         shall have paid to the Warrant Agent for the account of the Company the amount of such
                                         tax or charge, if any, or shall have established to the reasonable satisfaction of the
                                         Company and the Warrant Agent that such tax or charge, if any, has been paid.

    	3

    	 

    
		4.2.	Resignation,
                                         Consolidations, or Merger of the Warrant Agent.

		4.2.1.	Appointment
                                         of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed,
                                         may resign its duties and be discharged from all further duties and liabilities hereunder
                                         after giving thirty (30) days’ notice in writing to the Company, or such shorter
                                         period of time agreed to by the Company. The Company may terminate the services of the
                                         Warrant Agent, or any successor Warrant Agent, after giving thirty (30) days’ notice
                                         in writing to the Warrant Agent or successor Warrant Agent, or such shorter period of
                                         time as agreed. If the office of the Warrant Agent becomes vacant by resignation, termination,
                                         or incapacity to act or otherwise, the Company shall appoint in writing a successor Warrant
                                         Agent in place of the Warrant Agent. If the Company shall fail to make such appointment
                                         within a period of 30 days after it has been notified in writing of such resignation
                                         or incapacity by the Warrant Agent, then the Warrant Agent or any Holder may apply to
                                         any court of competent jurisdiction for the appointment of a successor Warrant Agent
                                         at the Company’s cost. Pending appointment of a successor to such Warrant Agent,
                                         either by the Company or by such a court, the duties of the Warrant Agent shall be carried
                                         out by the Company. Any successor Warrant Agent (but not including the immediate predecessor
                                         Warrant Agent), whether appointed by the Company or by such court, shall be a person
                                         organized and existing under the laws of any state of the United States of America, in
                                         good standing, and authorized under such laws to exercise corporate trust powers and
                                         subject to supervision or examination by federal or state authority. After appointment,
                                         any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities,
                                         duties, and obligations of its predecessor Warrant Agent with like effect as if originally
                                         named as Warrant Agent hereunder, without any further act or deed, and except for executing
                                         and delivering documents as provided in the sentence that follows, the predecessor Warrant
                                         Agent shall have no further duties, obligations, responsibilities, or liabilities hereunder,
                                         but shall be entitled to all rights that survive the termination of this Warrant Agent
                                         Agreement and the resignation or removal of the Warrant Agent, including but not limited
                                         to its right to indemnity hereunder. If for any reason it becomes necessary or appropriate
                                         or at the request of the Company, the predecessor Warrant Agent shall execute and deliver,
                                         at the expense of the Company, an instrument transferring to such successor Warrant Agent
                                         all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and
                                         upon request of any successor Warrant Agent the Company shall make, execute, acknowledge,
                                         and deliver any and all instruments in writing for more fully and effectually vesting
                                         in and confirming to such successor Warrant Agent all such authority, powers, rights,
                                         immunities, duties, and obligations.

		4.2.2.	Notice
                                         of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed,
                                         the Company shall give notice thereof to the predecessor Warrant Agent and the transfer
                                         agent for the Common Stock not later than the effective date of any such appointment.

		4.2.3.	Merger
                                         or Consolidation of Warrant Agent. Any person into which the Warrant Agent may be
                                         merged or converted or with which it may be consolidated or any person resulting from
                                         any merger, conversion, or consolidation to which the Warrant Agent shall be a party
                                         or any person succeeding to the shareowner services business of the Warrant Agent or
                                         any successor Warrant Agent shall be the successor Warrant Agent under this Warrant Agent
                                         Agreement, without any further act or deed. For purposes of this Warrant Agent Agreement,
                                         “person” shall mean any individual, firm, corporation, partnership, limited
                                         liability company, joint venture, association, trust, or other entity, and shall include
                                         any successor (by merger or otherwise) thereof or thereto.

    	4

    	 

    
		4.3.	Fees
                                         and Expenses of the Warrant Agent.

		4.3.1.	Remuneration.
                                         Whether or not any Warrants are exercised, for the Warrant Agent’s services as
                                         agent for the Company hereunder, the Company shall pay to the Warrant Agent such fees
                                         as may be separately agreed between the Company and Warrant Agent and the Warrant Agent’s
                                         out-of-pocket expenses in connection with this Warrant Agent Agreement, including, without
                                         limitation, the fees and expenses of the Warrant Agent’s counsel and the fees and
                                         expenses charged by the Warrant Agent in connection with exercises and transfers of the
                                         Warrants. While the Warrant Agent endeavors to maintain out-of-pocket charges (both internal
                                         and external) at competitive rates, these charges may not reflect actual out-of-pocket
                                         costs, and may include handling charges to cover internal processing and use of the Warrant
                                         Agent’s billing systems. All amounts owed by the Company to the Warrant Agent under
                                         this Warrant Agent Agreement are due within 30 days of the invoice date. Delinquent payments
                                         are subject to a late payment charge of one and one-half percent (1.5%) per month, commencing
                                         45 days from the invoice date. The Company agrees to reimburse the Warrant Agent for
                                         any attorneys’ fees and any other costs associated with collecting delinquent payments.
                                         No provision of this Warrant Agent Agreement shall require the Warrant Agent to expend
                                         or risk its own funds or otherwise incur any financial liability in the performance of
                                         any of its duties under this Warrant Agent Agreement or in the exercise of its rights.

		4.3.2.	Further
                                         Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause
                                         to be performed, executed, acknowledged, and delivered, all such further and other acts,
                                         instruments, and assurances as may reasonably be required by the Warrant Agent for the
                                         carrying out or performing of the provisions of this Warrant Agent Agreement.

    	5

    	 

    
		4.4.	Liability
                                         of the Warrant Agent.

		4.4.1.	Exclusions.
                                         As agent for the Company hereunder, the Warrant Agent: (a) shall have no duties or obligations
                                         other than those specifically set forth herein or as may subsequently be agreed to in
                                         writing by the Warrant Agent and the Company; (b) shall be regarded as making no representations
                                         and having no responsibilities as to the validity, sufficiency, value, or genuineness
                                         of the Warrants or any Warrant Shares; (c) shall not be obligated to take any legal action
                                         hereunder; if, however, the Warrant Agent determines to take any legal action hereunder,
                                         and where the taking of such action might, in its judgment, subject or expose it to any
                                         expense or liability it shall not be required to act unless it has been furnished with
                                         an indemnity reasonably satisfactory to it; (e) may rely on and shall be fully authorized
                                         and protected in acting or failing to act upon any certificate, instrument, opinion,
                                         notice, letter, telex, facsimile transmission, or other document or security delivered
                                         to the Warrant Agent and believed by it to be genuine and to have been signed by the
                                         proper party or parties; (f) shall not be liable or responsible for any recital or statement
                                         contained in the Registration Statement or any other documents relating thereto; (g)
                                         shall not be liable or responsible for any failure on the part of the Company to comply
                                         with any of its covenants and obligations relating to the Warrants, including without
                                         limitation obligations under applicable securities laws; (h) may rely on and shall be
                                         fully authorized and protected in acting or failing to act upon the written, telephonic,
                                         or oral instructions with respect to any matter relating to its duties as the Warrant
                                         Agent covered by this Warrant Agent Agreement (or supplementing or qualifying any such
                                         actions) of officers of the Company, and is hereby authorized and directed to accept
                                         instructions with respect to the performance of its duties hereunder from the Company
                                         or counsel to the Company, and may apply to the Company, for advice or instructions in
                                         connection with the Warrant Agent’s duties hereunder, and the Warrant Agent shall
                                         not be liable for any delay in acting while waiting for those instructions; any applications
                                         by the Warrant Agent for written instructions from the Company may, at the option of
                                         the Warrant Agent, set forth in writing any action proposed to be taken or omitted by
                                         the Warrant Agent under this Warrant Agent Agreement and the date on or after which such
                                         action shall be taken or such omission shall be effective; the Warrant Agent shall not
                                         be liable for any action taken by, or omission of, the Warrant Agent in accordance with
                                         a proposal included in such application on or after the date specified in such application
                                         (which date shall not be less than five (5) business days after the date such application
                                         is sent to the Company, unless the Company shall have consented in writing to any earlier
                                         date) unless prior to taking any such action, the Warrant Agent shall have received written
                                         instructions in response to such application specifying the action to be taken or omitted;
                                         (i) may perform any of its duties hereunder either directly or by or through nominees,
                                         correspondents, designees, or subagents, and it shall not be liable or responsible for
                                         any misconduct or negligence on the part of any nominee, correspondent, designee, or
                                         subagent appointed with reasonable care by it in connection with this Warrant Agent Agreement;
                                         (j) is not authorized, and shall have no obligation, to pay any brokers, dealers, or
                                         soliciting fees to any person; and (k) shall not be required hereunder to comply with
                                         the laws or regulations of any country other than the United States of America or any
                                         political subdivision thereof.

		4.4.2.	Limitation
                                         of Liability. In the absence of gross negligence or willful or illegal misconduct
                                         on its part, the Warrant Agent shall not be liable for any action taken, suffered, or
                                         omitted by it or for any error of judgment made by it in the performance of its duties
                                         under this Warrant Agent Agreement. Anything in this Warrant Agent Agreement to the contrary
                                         notwithstanding, in no event shall the Warrant Agent be liable for special, indirect,
                                         incidental, consequential, or punitive losses or damages of any kind whatsoever (including,
                                         but not limited to, lost profits), even if the Warrant Agent had been advised of the
                                         possibility of such losses or damages and regardless of the form of action. Any liability
                                         of the Warrant Agent will be limited in the aggregate to the amount of fees paid by the
                                         Company hereunder. In the event any question or dispute arises with respect to the proper
                                         interpretation of the Warrants or the Warrant Agent’s duties under this Warrant
                                         Agent Agreement or the rights of the Company or of any Registered Holder or beneficial
                                         owner, as applicable, the Warrant Agent shall not be required to act and shall not be
                                         held liable or responsible for its refusal to act until the question or dispute has been
                                         judicially settled (and, if appropriate, it may file a suit in interpleader or for a
                                         declaratory judgment for such purpose) by final judgment rendered by a court of competent
                                         jurisdiction, binding on all persons interested in the matter that is no longer subject
                                         to review or appeal, or settled by a written document in form and substance satisfactory
                                         to Warrant Agent and executed by the Company and each such Registered Holder or beneficial
                                         owner, as applicable. In addition, the Warrant Agent may require for such purpose, but
                                         shall not be obligated to require, the execution of such written settlement by all the
                                         Registered Holders and beneficial owners and all other persons that may have an interest
                                         in the settlement.

    	6

    	 

    
		4.4.3.	Indemnity.
                                         The Company agrees to indemnify the Warrant Agent and hold it harmless from and against
                                         any loss, liability, claim, or expense (a “Loss”) arising out of or
                                         in connection with the Warrant Agent’s duties under this Warrant Agent Agreement,
                                         including the costs and expenses of defending itself against any Loss, unless such Loss
                                         shall have been determined by a court of competent jurisdiction to be a result of the
                                         Warrant Agent’s gross negligence or willful misconduct.

		4.5.	Rights
                                         and Duties of the Warrant Agent.

		4.5.1.	Counsel.
                                         The Warrant Agent may consult with counsel satisfactory to the Warrant Agent, including
                                         its in-house counsel, and the advice of such counsel shall be full and complete authorization
                                         and protection in respect of any action taken, suffered, or omitted by it hereunder in
                                         good faith and in accordance with the advice of such counsel.

		4.5.2.	No
                                         Duty of Demand. The Warrant Agent shall not have any duty or responsibility in the
                                         case of the receipt of any written demand from any holder of Warrants with respect to
                                         any action or default by the Company, including, without limitation the generality of
                                         the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings
                                         at law or otherwise or to make any demand upon the Company.

		4.5.3.	Reliance
                                         on Attorneys and Agents. The Warrant Agent may execute and exercise any of the rights
                                         or powers hereby vested in it or perform any duty hereunder either itself or by or through
                                         its attorney or agents, and the Warrant Agent shall not be answerable or accountable
                                         for any act, default, neglect, or misconduct of any such attorney or agents or for any
                                         loss to the Company resulting from any such act default, neglect, or misconduct, absent
                                         gross negligence, bad faith, or willful misconduct (each as determined by a final non-appealable
                                         judgment of a court of competent jurisdiction in the selection and continued employment
                                         thereof.

		4.5.4.	Company
                                         Instructions. Any instructions given to the Warrant Agent orally, as permitted by
                                         any provision of this Warrant Agent Agreement, shall be confirmed in writing by the Company
                                         as soon as practicable. The Warrant Agent shall not be liable or responsible and shall
                                         be fully authorized and protected for acting, or failing to act, in accordance with any
                                         oral instructions that do not conform with the written confirmation received in accordance
                                         with this Section 4.5.4.

    	7

    	 

    

5.            Notices of Changes in Warrants. Upon every adjustment of the Exercise Price of a Warrant or the number of shares issuable
upon exercise of a Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Exercise
Price resulting from such adjustment and the increase or decrease, if any, in the number of shares purchasable at such price upon
the exercise of a Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation
is based. The Warrant Agent shall be fully protected in relying upon such a notice.

6.            Reservation of Warrant Shares. The Company shall at all times reserve and keep available a number of its authorized but
unissued shares of Common Stock that will be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant
to this Warrant Agent Agreement.

7.            Representations and Warranties of the Company. The Company represents and warrants that: (a) it is duly incorporated and
validly existing under the laws of its jurisdiction of incorporation; (b) the offer and sale of the Warrants and the execution,
delivery, and performance of all transactions contemplated thereby (including this Warrant Agent Agreement) have been duly authorized
by all necessary corporate action and will not result in a breach of or constitute a default under the Articles of Incorporation,
bylaws, or any similar document of the Company, or any indenture, agreement, or instrument to which it is a party or is bound;
(c) this Warrant Agent Agreement has been duly executed and delivered by the Company and constitutes the legal, valid, binding,
and enforceable obligation of the Company; (d) the Warrants will comply in all material respects with all applicable requirements
of law; and (e) to the best of its knowledge, there is no litigation pending or threatened as of the date hereof in connection
with the offering of the Warrants.

8.            Miscellaneous Provisions.

		8.1.	Loss,
                                         Theft, Destruction, or Mutilation of a Warrant. Upon receipt by the Company and the
                                         Warrant Agent of evidence reasonably satisfactory to them (including, posting a bond)
                                         of the loss, theft, destruction, or mutilation of a Warrant or any stock certificate
                                         relating to shares underlying the Warrants, and, in case of loss, theft, or destruction,
                                         of indemnity or security in customary form and amount, and reimbursement to the Company
                                         and the Warrant Agent of all reasonable expenses incidental thereto, and upon surrender
                                         to the Warrant Agent and cancellation of the Warrant or stock certificate, if mutilated,
                                         the Warrant Agent shall, on behalf of the Company, countersign and deliver a new Warrant
                                         or stock certificate of like tenor to the Registered Holder or beneficial owner, as applicable,
                                         in lieu of the Warrant or stock certificate so lost, stolen, destroyed, or mutilated.

		8.2.	Successors.
                                         This Warrant Agent Agreement shall inure to the benefit of and be binding upon the successors
                                         and assigns of the parties hereto.

    	8

    	 

    
		8.3.	Termination.
                                         Unless terminated earlier by the parties hereto, this Warrant Agent Agreement shall terminate
                                         90 days after the earlier of the Expiration Date and the date on which no Warrants remain
                                         outstanding (the “Termination Date”). On the Business Day following
                                         the Termination Date, the Warrant Agent shall deliver to the Company any entitlements,
                                         if any, held by the Warrant Agent under this Warrant Agent Agreement. The Warrant Agent’s
                                         right to be reimbursed for fees, charges, and out-of-pocket expenses as provided in this
                                         Section 8.3 shall survive the termination of this Warrant Agent Agreement.

		8.4.	Severability.
                                         If any provision of this Warrant Agent Agreement shall be held illegal, invalid, or unenforceable
                                         by any court, this Warrant Agent Agreement shall be construed and enforced as if such
                                         provision had not been contained herein and shall be deemed an agreement among the parties
                                         to it to the full extent permitted by applicable law.

		8.5.	Authorized
                                         Representatives. The Company shall, from time to time, certify to the Warrant Agent
                                         the names and signatures of any persons authorized to act for the Company under this
                                         Warrant Agent Agreement.

		8.6.	Notices.
                                         Except as expressly set forth elsewhere in this Warrant Agent Agreement, all notices,
                                         instructions, and communications under this Warrant Agent Agreement shall be in writing,
                                         shall be deemed to have been delivered: (i) upon receipt, if delivered personally; (ii)
                                         when sent, if sent by e-mail (provided that such sent e-mail is kept on file (whether
                                         electronically or otherwise) by the sending party and the sending party does not receive
                                         an automatically generated message from the recipient’s e-mail server that such
                                         e-mail could not be delivered to such recipient); and (ii) if sent by overnight courier
                                         service, one (1) Trading Day after deposit with an overnight courier service with next
                                         day delivery specified, in each case, properly addressed to the party to receive the
                                         same. The addresses and e-mail addresses for such communications shall be:

If
to the Company:

 

Modular
Medical, Inc.

16772
West Bernardo Drive

San
Diego, CA 92127

Attention:
Chief Executive Officer

contracts@modular-medical.com

 

with
a copy (which shall not constitute notice) to:

 

Gusrae
Kaplan Nusbaum PLLC

120
Wall Street, 25th Floor

New
York, NY 10005

Attention:
Lawrence G Nusbaum, Esq.

If
to the Warrant Agent:

[Address]

Attention:

    	9

    	 

    

Any notice,
statement, or demand authorized to be given or made by the Warrant Agent or the Company to the Registered Holder or beneficial
owner, as applicable of any Warrant shall be in writing and shall be delivered by hand or sent by first-class mail, postage prepaid,
or registered or certified mail or overnight courier service, addressed, at the last address set forth for such holder in the
Warrant Register. Any notice, sent pursuant to this Warrant Agent Agreement shall be effective, if delivered by hand, upon receipt
thereof by the party to whom it is addressed, if sent by overnight courier, on the next business day of the delivery to the courier,
if sent by registered or certified mail on the third business day after registration or certification thereof, and if sent by
first class mail on the fifth business day after mailing.

		8.7.	Applicable
                                         Law. This Warrant Agent Agreement shall be governed by and construed in accordance
                                         with the laws of the State of New York. All actions and proceedings relating to or arising
                                         from, directly or indirectly, this Warrant Agent Agreement may be litigated in courts
                                         located within the Borough of Manhattan in the City and State of New York. The Company
                                         hereby submits to the personal jurisdiction of such courts and consents that any service
                                         of process may be made by certified or registered mail, return receipt requested, directed
                                         to the Company at its address last specified for notices hereunder. Each of the parties
                                         hereto hereby waives the right to a trial by jury in any action or proceeding arising
                                         out of or relating to this Warrant Agent Agreement. 

		8.8.	Assignments.
                                         This Warrant Agent Agreement may not be assigned, or otherwise transferred, in whole
                                         or in part, by either party without the prior written consent of the other party, which
                                         the other party will not unreasonably withhold, delay, deny, or condition; except that
                                         (i) consent is not required for an assignment or delegation of duties by the Warrant
                                         Agent to any affiliate of the Warrant Agent and (ii) any reorganization, merger, consolidation,
                                         sale of assets, or other form of business combination by the Warrant Agent or the Company
                                         shall not be deemed to constitute an assignment of this Warrant Agent Agreement.

		8.9.	Amendments.
                                         No provision of this Warrant Agent Agreement may be amended, modified, or waived, except
                                         in a written document signed by both parties. The Company and the Warrant Agent may amend
                                         or supplement this Warrant Agent Agreement without the consent of any Registered Holder
                                         or beneficial owner, as applicable, for the purpose of curing any ambiguity, or curing,
                                         correcting, or supplementing any defective provision contained herein or adding or changing
                                         any other provisions with respect to matters or questions arising under this Warrant
                                         Agent Agreement as the parties may deem necessary or desirable and that the parties determine,
                                         in good faith, shall not adversely affect the interest of the Registered Holders and
                                         beneficial owners. All other amendments and supplements shall require the vote or written
                                         consent of the Registered Holders and beneficial owners of at least 50.1% of the then
                                         outstanding Warrants; provided, that, adjustments may be made to the Warrant
                                         terms and rights in accordance with the Warrants without the consent of the holders.

    	10

    	 

    
		8.10.	Persons
                                         Having Rights under this Warrant Agent Agreement. Nothing in this Warrant Agent Agreement
                                         expressed and nothing that may be implied from any of the provisions hereof is intended,
                                         or shall be construed, to confer upon, or give to, any person or corporation other than
                                         the parties hereto and the Holders any right, remedy, or claim under or by reason of
                                         this Warrant Agent Agreement or of any covenant, condition, stipulation, promise, or
                                         agreement hereof.

		8.11.	Examination
                                         of the Warrant Agent Agreement. A copy of this Warrant Agent Agreement shall be available
                                         at all reasonable times at the office of the Warrant Agent designated for such purpose
                                         for inspection by any Registered Holder or beneficial owner, as applicable. Prior to
                                         such inspection, the Warrant Agent may require any such holder to provide reasonable
                                         evidence of its interest in the Warrants.

		8.12.	Counterparts.
                                         This Warrant Agent Agreement may be executed in any number of original or electronic
                                         counterparts and each of such counterparts shall for all purposes be deemed to be an
                                         original, and all such counterparts shall together constitute but one and the same instrument.

		8.13.	Effect
                                         of Headings. The Section headings herein are for convenience only and are not part
                                         of this Warrant Agent Agreement and shall not affect the interpretation thereof.

		8.14.	Force
                                         Majeure. Notwithstanding anything to the contrary contained herein, the Warrant Agent
                                         shall not be liable for any failures, delays, or losses, arising directly or indirectly
                                         out of conditions beyond its reasonable control including, but not limited to, acts of
                                         government, exchange, or market ruling, suspension of trading, work stoppages, or labor
                                         disputes, fires, civil disobedience, riots, rebellions, storms, electrical or mechanical
                                         failure, computer hardware or software failure, communications facilities failures including
                                         telephone failure, war, terrorism, insurrection, earthquakes, floods, acts of God, or
                                         similar occurrences.

[Signature
Page to Follow]

    	11

    	 

    

IN WITNESS
WHEREOF, this Warrant Agent Agreement has been duly executed by the parties hereto as of the day and year first above written.

	MODULAR MEDICAL, INC.	 
	 	 	 
	By:	 	 
	 	Name:	 
	 	Title:	 
	 	 	 
	 	[_____________________________________]	 
	 	 	 
	By: 	 	 
	 	Name:	 
	 	Title:	 
	 	 	 

    	12

    	 

    

EXHIBIT
A

Form
of Investor Warrant

See attached.

    	13Exhibit 4.4

 

MODULAR
MEDICAL, INC.

SUBSCRIPTION
AGREEMENT

This
Subscription Agreement (this “Subscription Agreement”) is dated   ______ _, 2020, by
and between the undersigned identified on the Signature Page hereto (the “Investor”) and Modular Medical
, Inc., a Nevada corporation (the “Company”).

WHEREAS,
the Company has authorized the sale and issuance of 2,000,000 preferred units (the “Preferred Units”),
with each Preferred Unit consisting of (i) one share (a “Share”) of the Company’s 13% Series A
Cumulative Redeemable Perpetual Preferred Stock with a $25.00 liquidation preference amount (the “Series A Preferred
Stock”), and (ii) three (3) common stock purchase warrants, each to purchase one share of the Company’s common
stock (the “Warrant Shares”), at an initial exercise price of $11.00 per share (the “Warrants”
and together with the Shares and the Preferred Units, collectively, the “Purchased Securities”), at
a public offering price of $25.00 per Preferred Unit (the “Purchase Price”);

WHEREAS,
the sale of the Preferred Units (the “Offering”) is being made pursuant to an effective Registration
Statement on Form S-1 (File No.  ) (as amended and/or supplemented from time to time, the “Registration Statement”)
filed under the Securities Act of 1933, as amended (the “Securities Act”), by the Company with the U.S.
Securities and Exchange Commission (the “Commission”);

WHEREAS,
the Company and [name of Escrow Agent] (the “Escrow Agent”) have entered into an Escrow Agreement, dated
____ __, 2020 (the “Escrow Agreement”), pursuant to which the Escrow Agent has agreed to serve as the
escrow agent in connection with the Offering;

WHEREAS,
all funds for the purchase of Preferred Units in the Offering will prior to the closing of the Offering be deposited in a bank
account at _____ (Account No.: _____) (the “Escrow Account”) maintained by the Escrow Agent;

WHEREAS,
the Investor desires to purchase a certain amount of Preferred Units from the Company.

NOW,
THEREFORE, in consideration of the foregoing and of the covenants contained herein, the sufficiency of which is hereby mutually
accepted, the parties hereby agree as follows:

 

		1.	Subscription.

 

(a)       
Investor agrees to buy and the Company agrees to sell and issue to Investor such number of Preferred Units as set forth on the
signature page hereto (the “Signature Page”), for an aggregate purchase price equal to the product of
(x) the aggregate number of Preferred Units the Investor has agreed to purchase and (y) the Purchase Price.

(b)       
The Preferred Units are being offered by the Company on a “reasonable best efforts” basis. The completion of the purchase
and sale of the Preferred Units (the “Closing”) shall take place at a place and time to be specified
by the Company in accordance with Rule 15c6-1 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange
Act”).

    	 

    	 

    

		2.	Procedure.
                                         Prior to the Closing Date (as defined below), the Investor will:

 

		(a)	Subscription
                                         Agreement. Complete and execute this Subscription Agreement and deliver it to
                                         the Escrow Agent at the address set forth below for forwarding to the Company:

[Escrow
Agent]

___________________

___________________

___________________

Attn:

T:
(___) ________

F.:
(___) ________

 

		(b)	Delivery
                                         of Purchase Price. Deliver funds in an amount equal to the Purchase Price multiplied
                                         by the number of Preferred Units to which such Investor has subscribed to the Escrow
                                         Agent by:

(i)    
Wire Transfer: 

[Escrow
Agent]

_________________

_________________

ABA
No.:

Account
No.:             

 

(ii)  
Certified  Check:

make
certified payable to: “________, as Escrow Agent for Modular Medical, Inc.” and forward to:

[Escrow
Agent]

________________

________________

________________

Attn:
____________

T:
(__) _________

F.:
(__) _________

 

		3.	Closing
                                         Date; Termination Date. 

 

(a)   
As set forth in the Prospectus, the Preferred Units are being offered by the Company for a period that will commence on the date
of the Prospectus and terminate on the first to occur of (i) the date all of the Preferred Units have been fully subscribed for,
(ii) ____ __, 2020, or (iii) when the Company so determines, in its sole discretion, without notice (“Termination
Date”). No further subscriptions for the Preferred Units will be accepted by the Company after the Termination Date.
There is no minimum dollar amount or number of Preferred Units that must be sold to effectuate [the closing] [an initial or any
subsequent closing] of the Offering and all proceeds from subscribers of Preferred Units will be retained by the Company.

    	2

    	 

    

(b)  
At the time of Closing, at the direction of the Company, the Escrow Agent will release the balance of the Escrow Account
for collection by the Company as provided in the Escrow Agreement and the Company shall deliver to the Investor the Purchased
Securities being purchased on the Closing Date, through the facilities of DTC, and such Purchased Securities shall be registered
in the names of the Investors in the denominations set forth in the Subscription Agreements. The Shares and the Warrants
included in the Preferred Units will be immediately separable upon delivery. The date on which the Escrow Agent releases the balance
of the Escrow Account for collection by the Company against delivery of the Preferred Units to the Investors as described above,
is hereinafter referred to as the “Closing Date.”

 

4.     Return of Funds. Upon the occurrence of the Termination Date, the Escrow Agent will promptly return the
funds to the Investors without interest or deduction.

5.     Investor Representations.

 

		(a)	The
                                         Investor represents that it has received (or otherwise had made available to it by the
                                         filing by the Company of an electronic version thereof with the Commission) the final
                                         prospectus in connection with the Registration Statement pursuant to Rule 424(b) of the
                                         Securities Act, prior to or in connection with the receipt of this Subscription Agreement.

		(b)	The
                                         Investor represents that it understands and hereby acknowledges that the Investor’s
                                         subscription for the Preferred Units indicated on the Signature Page hereto may be accepted
                                         or rejected in whole or in part by the Company, for any reason or no reason, and in its
                                         sole and absolute discretion.

		(c)	The
                                         Investor represents that (i) it has had no position, office or other material relationship
                                         within the past three years with the Company or persons known to it to be affiliates
                                         of the Company, (ii) it is not a member of the Financial Industry Regulatory Authority,
                                         Inc. (“FINRA”) or an Associated Person (as such term
                                         is defined under the FINRA’s NASD Membership and Registration Rules Section 1011)
                                         as of the Closing, and (iii) neither the Investor nor any group of Investors (as
                                         such term is used in Rule 13d-5 under the Exchange Act (as defined below)) of which the
                                         Investor is a part in connection with the Offering, has acquired, or obtained the right
                                         to acquire, 10% or more of the common stock of the Company (or securities convertible
                                         into or exchangeable or exercisable for common stock of the Company) or the voting power
                                         of the Company on a post-transaction basis.

    	3

    	 

    

6.     Acceptance. No offer by the Investor to buy Preferred Units will be accepted and no part of the Purchase Price will
be delivered to the Company until the Company has accepted such offer, or a portion thereof, by countersigning a copy of this
Subscription Agreement and delivering a fully-executed version of this Subscription Agreement, and any such offer may be withdrawn
or revoked, without obligation or commitment of any kind, at any time prior to such execution and delivery by the Company. If
the Company rejects a subscription, or a portion thereof, for the Preferred Units, the deposited Purchase Price for the rejected
subscription, or a portion thereof as the case may be, shall be returned by the Escrow Agent to the Investor, without interest
thereon or deduction therefrom.

7.     Company Confirmation. The Investor acknowledges and agrees that such Investor’s receipt of the Company’s
signed counterpart to this Subscription Agreement, together with the Prospectus (or the filing by the Company of an electronic
version thereof with the Commission), shall constitute written confirmation of the Company’s sale of the Preferred Units
to such Investor.

8.     Not a Firm Commitment Offering. The Investor acknowledges that the Offering is being conducted on a “reasonable
best efforts” basis and is not being underwritten on a “firm commitment” basis. The Company, however, receives
the right to pay broker/dealers (“Selling Agents”) up to 8.0% of the purchase price paid by any Purchasers
in this Offering that was introduced to the Company by the Selling Agents.

9.     Notices. All communications hereunder, except as herein otherwise specifically provided, shall be in writing and
shall be mailed (registered or certified mail, return receipt requested), personally delivered or sent by facsimile transmission
and confirmed, or by electronic transmission via PDF, and shall be deemed given when so delivered or faxed and confirmed or transmitted
or if mailed, two days after such mailing.

	 	If
to the Escrow Agent:

[Escrow
Agent].

_________________

_________________

_________________

Attn:
_____________

 

If
to the Company:

Modular
Medical, Inc.

16772
W. Bernardo Drive

San
Diego, California 92127

Attn:
Chief Executive Officer

contracts@modular-medical.com

 

With
a copy (which shall not constitute notice) to:

Gusrae
Kaplan Nusbaum PLLC

120
Wall Street, 25th Floor

New
York, New York 10005

Attn:
Lawrence G. Nusbaum

    	4

    	 

    

10.  
Changes. This Subscription Agreement may not be modified or amended except pursuant to an instrument in writing
signed by the Company and the Investor.

11.  
Headings. The headings of the various sections of this Subscription Agreement have been inserted for convenience
of reference only and will not be deemed to be part of this Subscription Agreement.

12.  
Severability. In case any provision contained in this Subscription Agreement is invalid, illegal or unenforceable
in any respect, the validity, legality and enforceability of the remaining provisions contained herein will not in any way be
affected or impaired thereby.

13.  
Governing Law. This Subscription Agreement will be governed by, and construed in accordance with, the internal laws
of the State of New York, without giving effect to the principles of conflicts of law that would require the application of the
laws of any other jurisdiction. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense
of the transactions contemplated by this Subscription Agreement and any other this Subscription Agreement (whether brought against
a party hereto or its respective affiliates, directors, officers, shareholders, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, borough of Manhattan for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement
of any of this Subscription Agreement), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding,
any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper
or is an inconvenient venue for such proceeding.

14.  
Counterparts. This Subscription Agreement may be executed in two or more counterparts, each of which will constitute
an original, but all of which, when taken together, will constitute but one instrument, and will become effective when one or
more counterparts have been signed by each party hereto and delivered to the other parties.

[SIGNATURE
PAGE FOLLOWS]

    	5

    	 

    

IN
WITNESS WHEREOF, the Investor has executed this Subscription Agreement as of the date written below.

	 	 	 
	Issuer:	 	Modular
    Medical, Inc.
	 	 
	Purchase
    Price :	 	$            
	 	 
	Number
    of Preferred Units  being Purchased by Investor:	 	 
	 	 
	Total
    Purchase Price (Number of Preferred Units  multiplied by Purchase Price):	 	$            

	 	 	 	 	 	 	 
	INVESTOR:	 	 	 	CO-INVESTOR
    (if any):
	 	 	 
	 	 	 	 	 
	Name
    of Investor	 	 	 	Name
    of Co-Investor, if applicable
	 	 	 
	 	 	 	 	 
	Signature
    of Investor	 	 	 	Signature
    of Co-Investor, if applicable
	 	 	 
	 	 	 	 	 
	Social
    Security Number (SSN) or Fed Tax ID (EIN)	 	 	 	Social
    Security Number (SSN) or Fed Tax ID (EIN)
	 	 	 
	Date: 	                    	 	 	 	Date: 	                     

The
Preferred Unis subscribed for hereby are being purchased as follows:

(Check
One)

         individually

         joint
tenants

         joint
tenants with right of survivorship

         tenants
in common

         partnership

         limited
liability company

            as
custodian, trustee or agent for

                       
                                 corporation 

    	6

    	 

    

	Investor’s
    Name and	 	 	 	Co-Investor’s
    Name and Business
	Business
    Address (please print or type)	 	 	 	Address
    (please print or type):
	Phone
    Number/Email address	 	 	 	Phone
    Number/Email Address
	 	 	 
	 	 	 	 	 
	 	 	 
	 	 	 	 	 
	 	 	 
	 	 	 	 	 
	 	 	 
	 	 	 	 	 

	 	 	 	 	 
	Investor’s
    Residence Address	 	 	 	Co-Investor’s
    Residence Address
	(please
    print or type):	 	 	 	(please
    print or type):
	 	 	 
	 	 	 	 	 
	 	 	 
	 	 	 	 	 
	 	 	 
	 	 	 	 	 

 

 

The
foregoing Subscription is hereby accepted.

	 	 	 
	 	MODULAR MEDICAL, INC.
	 	 	
	 	By: 	
	 	 	Name: Paul DiPerna
	 	 	 
	 	 	Title: Chairman, Chief Executive
	 	 	 
	 	 	Officer, Chief Financial Officer,
	 	 	 
	 	 	Secretary and Treasurer

    	7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}]]